Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Schedule of Stock Options Activity (Details)

v3.24.1.1.u2
Stockholders' Equity - Schedule of Stock Options Activity (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]    
Number of shares options outstanding - beginning (in shares) 2,951  
Number of shares options granted (in shares) 1,790  
Number of shares options forfeited (in shares) (289)  
Number of shares options outstanding - ending (in shares) 4,452 2,951
Number of shares options vested and exercisable (in shares) 2,235  
Weighted Average Exercise Price     
Weighted average exercise price, beginning (in dollars per share) $ 7.30  
Weighted average exercise price, granted (in dollars per share) 6.00  
Weighted average exercise price, forfeited (in dollars per share) 8.81  
Weighted average exercise price, ending (in dollars per share) 6.68 $ 7.30
Weighted average exercise price, options vested and exercisable (in dollars per share) $ 6.43  
Weighted Average Remaining Contractual Life (in years)    
Weighted average remaining contractual life (in years) 5 years 7 months 6 days 4 years 9 months 18 days
Weighted average remaining contractual life, granted shares (in years) 7 years  
Weighted average remaining contractual life, options vested and exercisable (in years) 4 years 8 months 12 days  
Total intrinsic value, outstanding, beginning $ 693  
Total intrinsic value, outstanding, ending 3,012 $ 693
Total intrinsic value, options vested and exercisable $ 2,290